TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 131 filers reported holding TRANSENTERIX INC in Q3 2019. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $23,000 | -51.1% | 37,116 | 0.0% | 0.00% | – |
| Q2 2019 | $47,000 | -34.7% | 37,116 | +21.7% | 0.00% | – |
| Q1 2019 | $72,000 | +12.5% | 30,504 | +6.8% | 0.00% | – |
| Q4 2018 | $64,000 | -54.9% | 28,558 | +16.6% | 0.00% | – |
| Q3 2018 | $142,000 | +40.6% | 24,499 | +5.3% | 0.00% | – |
| Q2 2018 | $101,000 | +818.2% | 23,272 | +162.0% | 0.00% | – |
| Q1 2017 | $11,000 | -8.3% | 8,883 | -0.7% | 0.00% | – |
| Q4 2016 | $12,000 | – | 8,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |